Journal
CELL REPORTS
Volume 13, Issue 5, Pages 1059-1071Publisher
CELL PRESS
DOI: 10.1016/j.celrep.2015.09.051
Keywords
-
Categories
Funding
- Hematology laboratory, Pole de biologie, CHU de Rennes, France
- Ligue Nationale contre le Cancer (Equipe labellisee)
- European Union's Seventh Framework Program through the Blueprint Consortium
- La Ligue contre le Cancer/Region Bretagne
- CNRS
- University of Rennes 1
- La Ligue contre le Cancer
- Canceropole Grand Ouest
- Ministere de l'enseignement superieur et de la recherche
Ask authors/readers for more resources
Molecular mechanisms underlying terminal differentiation of B cells into plasma cells are major determinants of adaptive immunity but remain only partially understood. Here we present the transcriptional and epigenomic landscapes of cell subsets arising from activation of human naive B cells and differentiation into plasmablasts. Cell proliferation of activated B cells was linked to a slight decrease in DNA methylation levels, but followed by a committal step in which an S phase-synchronized differentiation switch was associated with an extensive DNA demethylation and local acquisition of 5-hydroxymethylcytosine at enhancers and genes related to plasma cell identity. Downregulation of both TGF-b1/SMAD3 signaling and p53 pathway supported this final step, allowing the emergence of a CD23-negative subpopulation in transition from B cells to plasma cells. Remarkably, hydroxymethylation of PRDM1, a gene essential for plasma cell fate, was coupled to progression in S phase, revealing an intricate connection among cell cycle, DNA (hydroxy) methylation, and cell fate determination.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available